Drug intelligence / Profile preview

Zhuli Capsule

Development stage: Phase 4
Lead developer: Zhong Wang
Modality: Small Molecules
Administration: Oral

Overview

Zhuli Capsule is a Traditional Chinese Medicine (TCM) formulation derived from the extract of bamboo species, specifically *Phyllostachys glauca* McClure or *Phyllostachys nuda* McClure. It is primarily utilized for its expectorant properties to treat Phlegm-heat Syndrome (Tan-re Zheng) in patients experiencing acute exacerbations of chronic obstructive pulmonary disease (AECOPD) or chronic bronchitis. The treatment aims to facilitate the clearance of sputum and improve clinical control rates when used as an adjunct to standard medical therapies, such as bronchodilators, glucocorticoids, or antibacterial drugs. It is currently being evaluated in Phase 4 clinical trials under the sponsorship of Dr. Zhong Wang.

Brand names: Zhuli Capsule
Other names: ZhuliPhyllostachys glauca extractPhyllostachys nuda extract

Beyond the preview

Go deeper on Zhuli Capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Zhuli Capsule.

Explore the full profile